Prospects for HIV control in South Africa: a model-based analysis

Global Health Action

Volumn 9, Issue 1, 2016, Pages

  Johnson, Leigh F ^a   Chiu, Calvin ^b   Myer, Landon ^a   Davies, Mary Ann ^a   Dorrington, Rob E ^a   Bekker, Linda Gail ^a   Boulle, Andrew ^a   Meyer Rath, Gesine ^b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

HIV AIDS; mathematical model; South Africa

Indexed keywords

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY; ARTICLE; BREAST FEEDING; CHILD; CIRCUMCISION; CONDOM USE; CONTROLLED STUDY; CORRELATION COEFFICIENT; COUNSELING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; NONHUMAN; PREGNANCY; PROBABILITY; RISK FACTOR; RISK REDUCTION; SOUTH AFRICA; UNCERTAINTY; HIV INFECTIONS; MALE; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; THEORETICAL MODEL; TRANSMISSION; VERTICAL TRANSMISSION;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTI-HIV AGENTS; CHILD; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MODELS, THEORETICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SOUTH AFRICA;

EID: 85011387990     PISSN: None     EISSN: 16549880     Source Type: Journal    
DOI: 10.3402/gha.v9.30314     Document Type: Article

References (60)

1. UNAIDS. Global Report: UNAIDS report on the global AIDS epidemic 2013. 2013. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf [cited 13 April 2014].
2. Bor J, Herbst AJ, Newell ML, Bärnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013; 339: 961–5.
3. Goga AE, Dinh TH, Jackson DJ, Lombard C, Delaney KP, Puren A, etal. First population-level effectiveness evaluation of a national programme to prevent HIV transmission from mother to child, South Africa. J Epidemiol Community Health. 2015; 69: 240–8.
4. Rehle T, Johnson L, Hallett T, Mahy M, Kim A, Odido H, etal. A comparison of South African national HIV incidence estimates: a critical appraisal of different methods. PLoS One. 2015; 10: e0133255.
5. Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, etal. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med. 2006; 3: e262.
6. Walensky RP, Park JE, Wood R, Freedberg KA, Scott CA, Bekker LG, etal. The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clin Infect Dis. 2012; 54: 1504–13.
7. Vickerman P, Terris-Prestholt F, Delany S, Kumaranayake L, Rees H, Watts C. Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa. Sex Transm Dis. 2006; 33(Suppl l):S122–32.
8. Little K, Newell ML, Luo C, Ngongo N, Borja MC, McDermott P. Estimating the number of vertically HIV-infected children eligible for antiretroviral treatment in resource-limited settings. Int J Epidemiol. 2007; 36: 679–87.
9. Andersson KM, Paltiel AD, Owens DK. The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results. Vaccine. 2011; 29: 6107–12.
10. Hontelez JA, Lurie MN, Bärnighausen T, Bakker R, Baltussen R, Tanser F, etal. Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med. 2013; 10: e1001534.
11. Verguet S. Efficient and equitable HIV prevention: a case study of male circumcision in South Africa. Cost Eff Resour Alloc. 2013; 11: 1.
12. Wilson DP, Kahn J, Blower SM. Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: the effect of the urban-rural divide. Proc Natl Acad Sci U S A. 2006; 103: 14228–33.
13. Andrews JR, Wood R, Bekker LG, Middelkoop K, Walensky RP. Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. J Infect Dis. 2012; 206: 543–51.
14. Cremin I, Alsallaq R, Dybul M, Piot P, Garnett G, Hallett TB. The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS. 2013; 27: 447–58.
15. Long EF, Stavert RR. Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. J Gen Intern Med. 2013; 28: 1294–301.
16. Brookmeyer R, Boren D, Baral SD, Bekker LG, Phaswana-Mafuya N, Beyrer C, etal. Combination HIV prevention among MSM in South Africa: results from agent-based modeling. PLoS One. 2014; 9: e112668.
17. Stover J, Hallett TB, Wu Z, Warren M, Gopalappa C, Pretorius C, etal. How can we get close to zero? The potential contribution of biomedical prevention and the Investment Framework towards an effective response to HIV. PLoS One. 2014; 9: e111956.
18. Stockman JK, Schwarcz SK, Butler LM, de Jong B, Chen SY, Delgado V, etal. HIV prevention fatigue among high-risk populations in San Francisco. J Acquir Immune Defic Syndr. 2004; 35: 432–4.
19. UNAIDS. Ambitious treatment targets: writing the final chapter of the AIDS epidemic. 2014; Geneva.Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/JC2670_UNAIDS_Treatment_Targets_en.pdf [cited 19 August 2014].
20. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009; 373: 48–57.
21. Mahy M, Stover J, Kiragu K, Hayashi C, Akwara P, Luo C, etal. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect. 2010; 86(Suppl 2):ii48–55. [PubMed Abstract] [PubMed CentralFull Text].
22. Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, Bershteyn A, etal. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012; 9: e1001245.
23. Johnson LF, Rehle TM, Jooste S, Bekker LG. Rates of HIV testing and diagnosis in South Africa, 2002–2012: successes and challenges. AIDS. 2015; 29: 1401–9.
24. Fraser C, Hollingsworth TD, Chapman R, de Wolf F, Hanage WP. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A. 2007; 104: 17441–6.
25. Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int Stat Rev. 1994; 62: 229–43.
26. Bärnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011; 11: 942–51.
27. Luque-Fernandez MA, Van Cutsem G, Goemaere E, Hilderbrand K, Schomaker M, Mantangana N, etal. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One. 2013; 8: e56088.
28. Chang LW, Kagaayi J, Nakigozi G, Ssempijja V, Packer AH, Serwadda D, etal. Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial. PLoS One. 2010; 5: e10923.
29. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, etal. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010; 376: 1838–45.
30. Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, etal. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection. N Engl J Med. 2013; 369: 1807–18.
31. Estill J, Tweya H, Egger M, Wandeler G, Feldacker C, Johnson LF, etal. Tracing of patients lost to follow-up and HIV transmission: mathematical modeling study based on 2 large ART programs in Malawi. J Acquir Immune Defic Syndr. 2014; 65: e179–86.
32. Bemelmans M, Baert S, Goemaere E, Wilkinson L, Vandendyck M, van Cutsem G, etal. Community-supported models of care for people on HIV treatment in sub-Saharan Africa. Trop Med Int Health. 2014; 19: 968–77.
33. Phillips T, Thebus E, Bekker LG, McIntyre J, Abrams EJ, Myer L. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study. J Int AIDS Soc. 2014; 1719242, doi: http://dx.doi.org/10.7448/IAS.17.1.19242.
34. Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, etal. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi. AIDS. 2014; 28: 589–98.
35. Fisher JD, Cornman DH, Shuper PA, Christie S, Pillay S, Macdonald S, etal. HIV prevention counseling intervention delivered during routine clinical care reduces HIV risk behavior in HIV-infected South Africans receiving antiretroviral therapy: the Izindlela Zokuphila/Options for Health randomized trial. J Acquir Immune Defic Syndr. 2014; 67: 499–507.
36. Saleh-Onoya D, Reddy PS, Ruiter RAC, Sifunda S, Wingood G, Van den Borne B. Condom use promotion among isiXhosa speaking women living with HIV in the Western Cape Province, South Africa: a pilot study. AIDS Care. 2009; 21: 817–25.
37. Phillips AN, Pillay D, Garnett G, Bennett D, Vitoria M, Cambiano V, etal. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. AIDS. 2011; 25: 843–50.
38. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2013. Available from: http://www.who.int/hiv/pub/guidelines/arv2013/en/ [cited 3 September 2013].
39. Johnson LF, Stinson K, Newell ML, Bland RM, Moultrie H, Davies MA, etal. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2012; 59: 417–25.
40. Drake AL, Wagner A, Richardson B, John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med. 2014; 11: e1001608.
41. Stinson K, Jennings K, Myer L. Integration of antiretroviral therapy services into antenatal care increases treatment initiation during pregnancy: a cohort study. PLoS One. 2013; 8: e63328.
42. Dryden-Peterson S, Lockman S, Zash R, Lei Q, Chen JY, Souda S, etal. Initial programmatic implementation of WHO Option B in Botswana associated with increased projected MTCT. J Acquir Immune Defic Syndr. 2015; 68: 245–9.
43. Dickson KE, Tran NT, Samuelson JL, Njeuhmeli E, Cherutich P, Dick B, etal. Voluntary medical male circumcision: a framework analysis of policy and program implementation in eastern and southern Africa. PLoS Med. 2011; 8: e1001133.
44. Londish GJ, Murray JM. Significant reduction in HIV prevalence according to male circumcision intervention in sub-Saharan Africa. Int J Epidemiol. 2008; 37: 1246–53.
45. Kong X, Kigozi G, Nalugoda F, Musoke R, Kagaayi J, Latkin C, etal. Assessment of changes in risk behaviors during 3 years of posttrial follow-up of male circumcision trial participants uncircumcised at trial closure in Rakai, Uganda. Am J Epidemiol. 2012; 176: 875–85.
46. Gray R, Kigozi G, Kong X, Ssempiija V, Makumbi F, Wattya S, etal. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS. 2012; 26: 609–15.
47. Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, Bouscaillou J, etal. Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013; 10: e1001509.
48. Karmon E, Potts M, Getz WM. Microbicides and HIV: help or hindrance?. J Acquir Immun Defic Syndr. 2003; 34: 71–5.
49. Foss AM, Vickerman PT, Heise L, Watts CH. Shifts in condom use following microbicide introduction: should we be concerned?. AIDS. 2003; 17: 1227–37.
50. Smith RJ, Bodine EN, Wilson DP, Blower SM. Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers. AIDS. 2005; 19: 413–21.
51. Bongaarts J. Late marriage and the HIV epidemic in sub-Saharan Africa. Popul Stud. 2007; 61: 73–83.
52. Baird SJ, Garfein RS, McIntosh CT, Özler B. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012; 379: 1320–9.
53. Cluver L, Boyes M, Orkin M, Pantelic M, Molwena T, Sherr L. Child-focused state cash transfers and adolescent risk of HIV infection in South Africa: a propensity-score-matched case-control study. Lancet Glob Health. 2013; 1: e362–70.
54. Cho H, Hallfors DD, Mbai II, Itindi J, Milimo BW, Halpern CT, etal. Keeping adolescent orphans in school to prevent human immunodeficiency virus infection: evidence from a randomized controlled trial in Kenya. J Adolesc Health. 2011; 48: 523–6.
55. Mulongeni P, Johnson LF. Epidemiological synergy: the role of heterosexual HIV transmission in the spread of HIV among men who have sex with men in South Africa. 21st International AIDS Conference, Durban, South Africa, 18–22 July 2016.
56. Leggett T, Abdool Karim SS, Abdool Karim Q. Intravenous drug use in South Africa. 2010; Cape Town: Cambridge University Press. 240–9. HIV/AIDS in South Africa. 2nd ed.
57. Gouws E, Cuchi P. Focusing the HIV response through estimating the major modes of HIV transmission: a multi-country analysis. Sex Transm Infect. 2012; 88(Suppl 2):i76–85.
58. Payne R, Muenchhoff M, Mann J, Roberts HE, Matthews P, Adland E, etal. Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence. Proc Natl Acad Sci U S A. 2014; 111: E5393–400.
59. Herbeck JT, Müller V, Maust BS, Ledergerber B, Torti C, Di Giambenedetto S, etal. Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission. AIDS. 2012; 26: 193–205.
60. South African National AIDS Council. Progress report on the national strategic plan for HIV, TB and STIs (2012–2016). 2014. Pretoria. Available from: http://www.sanac.org.za/publications/reports [cited 15 February 2015].